CME Hours / Accreditation Information:
This activity is being sponsored by Boston University School of Medicine.
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Boston University School of Medicine designates this educational activity for a maximum of 5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Each module will require about 1.25 hours per week for up to 5 weeks of participation. Participation includes reading and listening to online presentations, taking part in online group discussions, reading and responding to in-depth case studies, applying knowledge and practice to patients, and completing a final self-evaluation.
Term of Approval
Date of Release: November, 2008
Expiration Date: November, 2011
Course Director
John M. Wiecha, MD, MPH
Associate Professor
Director, Distance Education for Health
Director of Predoctoral Education
Department of Family Medicine
Boston University School of Medicine
Faculty Member has nothing to disclose with regards to commercial interests.
Course Faculty
Frank Domino, MD
Associate Professor and Clerkship Director,
University of Massachusetts Medical School
Attending Physician,
UMass-Memorial Health Care
Faculty member is a stockholder in RxPalm, Inc., and a Consultant for Wolters Kluwer, Inc. Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.
Shannon Jenkins, MD
Assistant Professor
Department of Political Science
University of Massachusetts
Faculty member has nothing to disclose with regard to commercial support. Faculty member does not plan on discussion unlabeled/investigational uses of a commercial product.
Stacey Potts, MD
Residency Director
University of Massachusetts Medical School Worcester Family Medicine Residency
Faculty member has nothing to disclose with regard to commercial support. Faculty member does not plan on discussion unlabeled/investigational uses of a commercial product.
Disclosure Policy
Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) activities to disclose all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve apparent conflicts of interest. In addition, faculty members are asked to disclose when any discussion of unapproved use of pharmaceuticals and devices occurs.
Unlabeled/investigational uses of commercial products are not discussed in this activity.
Target Audience
Primary care physicians.
Educational Needs Addressed
The care of patients post myocardial infarction requires a multidisciplinary approach. Such patients will benefit substantially from cardiac rehabilitation, yet physicians do not consistently refer patients for these services.1,2,3 Likewise, although there is robust evidence that use of beta blockers, ACE inhibitors, and aspirin post-MI result in improved outcomes, prescribing rates and patient compliance rates remain suboptimal.4 In addition, recent research has established the importance of depression as a risk factor for poor post- MI outcomes.5,6
1 Grace SL, et al. Contribution of patient and physician factors to cardiac rehabilitation enrollment: a prospective multilevel study. Eur J Cardiovasc Prev Rehabil. 2008 Oct;15(5):548-556.
2 Scott LB. Referral to outpatient cardiac rehabilitation: intervention research at the patient, provider, and health system levels. Nat Clin Pract Cardiovasc Med. 2008 Oct;5(10):671-2. Epub 2008 Aug 12.
3 Grace SL, Grewel K, Stewart, DE. Factors affecting cardiac rehabilitation referral by physician specialty. J Cardiopulm Rehabil Prev. 2008 Jul-Aug;28(4):248-52.
6 Dickens C, et al. New onset depression following myocardial infarction predicts cardiac mortality. Psychosom Med. 2008 May;70(4):450-5. Epub 2008 Apr 23.
Educational Objectives
At the conclusion of this activity, participants will be able to:
- State the role depression and anxiety play in pre and post MI states.
- Discuss depression treatment methods and outcome data in the post MI patient.
- Describe the data and mandate of cardiac rehabilitation.
- Propose a cardiac rehabilitation practice improvement process.
- Articulate the importance of initiating medications after MI to decrease morbidity and mortality.
- Explain the medications used for symptomatic treatment and improved quality of life after MI.
- Implement proper medical management after certain coronary interventions associated with MI.
- Describe the importance of lifestyle modification in the care of patients following myocardial infarction.
- Describe the components of comprehensive lifestyle modification and risk reduction.
- Apply these recommendations to your patients in the inpatient and outpatient settings.
Disclaimer
THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. NEITHER TRUSTEES OF BOSTON UNIVERSITY NOR THE DEVELOPERS OF THE MATERIALS MAKE ANY WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY, OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL THE TRUSTEES OF BOSTON UNIVERSITY OR THE DEVELOPERS OF THESE MATERIALS BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.
Funding
This project was made possible through a grant from the Physicians' Foundation for Health Systems Excellence and is supported in part by unrestricted educational grants from Pfizer, GlaxoSmithKline, The Olympus Medical Charitable Foundation, and the Beckman Coulter Foundation.
|
